MEBO Management

MEBO Group as an international technology and industry group, whose scientific achievements should be commercialized to show its high-tech value. To fulfill this ultimate goal, MEBO established Management System involving three sub-systems of enterprise (manufacturing), sales and marketing as well as trading.

Enterprises/Manufacturing

As early as the year of 1991, taking advantage of the favorite policy for Special Economic Zone, MEBO Group set up Shantou MEBO Pharmaceutical Manufactory in Shantou Special Economic Zone. The facility conforms to GMP with a potential productivity of million tubes of MEBO ointments annually. Both technology forces and facility meet international standards. The manufactory put the group's initial scientific achievements ---- Moist Exposed Burn Ointment into the international market by large quantity and standardized production methods, which provides a quality guarantee to create "MEBO"--- an international well-know trademark.

With the growing of the group, a pilot Pharmaceutical Manufactory of Beijing Guangming Chinese Medicine Institute for Burns, Wounds and Ulcers was set up in Beijing to satisfy the gradually increasing market demands. The Manufactory is responsible for the production of MEBO ointment for domestic market, the development of new products, pilot production and the production of skincare products. Besides, it undertakes an important task to ensure that there are matured products being marketed, newly developed products being under pilot production and new projects being studied continually. The series MEBO products have been developed and marketed one by one in recent years include SCAReducer, Cleansing Cream, Irritation Cream and Dermhealth Cream. All of them, made with active botanic ingredients and MEBO base which have a function of physiological metabolism, are developed on the basis of the skin repairing and regenerating theory proposed by Professor Rongxiang Xu. At mean time, a number of new series productssuch as MEBO Protection Cream, Nutrition Cream, Seawater and Sunburn-proof Cream have passed semi-phase trial. And other functional new products with breakthrough features are under study.

Workers are manufacturing MEBO burn ointment

From 1996 the Group has entered into an era of high-speed development. To keep up the forward steps and launch advanced research, the group has invested about 200 million Chinese yuan in building "Xu Rongxiang's Life-Science City" in Chinese Youth Technology Zone. The City, covering a total area of 45000 square meters, is designed to be built into a modernized and comprehensive architectural complex, integrating research, production, trade, medical treatment as well as service. It includes GMP-conforming Pharmaceutical Building, Center Laboratory Building, Commerce and Trade Building. At present, the complex has completed first phase of construction and the second is undergoing.

Meanwhile, the group holds the strategy to independently or jointly set up overseas pharmaceutical manufactories under the premise of matured condition, by which Chinese MEBO series products are introduced into the world market. Julphar of the United Arab Emirates, the largest pharmaceuticals in Middle East, and Unipharma of Syria have separately established the cooperation relationship with MEBO Group. They manufacture MEBO medicines and skin care products for countries in Middle East since it is more easily accepted by local people when medicines are jointly manufactured in their own countries. In addition, Thailand MEBO Pharmaceuticals is planned to establish by registered Thailand MEBO Corporation Ltd. to satisfy the demands from Southeast Asia market. The similar projects such as setting up a manufactory and laboratory in U.S.A are also taken into consideration.

Marketing

Marketing and Sale is a lifeline that the Group relies on to expand economic power. MEBO Group puts the great stress on the role of medical technique which pioneers to explore the markets as well as the corresponding policy of area marketing & sale.

All of the marketed products by MEBO group are of high-tech featured with scientific breakthroughs and forerunning concept and developed in accordance with Professor Rongxiang Xu's concept of life science. So it becomes the primary element to spreading the medical technique prior to marketing. Following the principle, there are special agencies and full-time staff at various levels ranging from head office to area offices to be engaged in technique marketing. Take the marketing of MEBO ointment as an example. The Software Office, consisting of experts and doctors with rich experiences in clinic with MEBT/MEBO, is in charge of spreading and popularizing the technique by training professional doctors to use MEBT/MEBO and setting up a national medical network. All these work are served as the initial steps for ultimately entering into medical market. It is proven by experiences of past decade that only based on medical network participated by nearly 9000 trained doctors and 5000 hospitals, could the market of MEBO ointment keep a constant vitality. The pattern of the technique pioneering marketing, is also applicable for marketing other medicinal products, skin care products and nutritional products as well.

The Marketing and Sale is characterized by the combination of the principle of the technique pioneering market and the system of area management.

The system of area management is composed of management at four levels, namely, head office, regional office, area general office and area office. The head office, as the commander of the system, performs macro-adjustment by working out policies, plans, regulations, measures as well as pricing to respond the market and general policy.The regional general managers and area general managers, however, according to the actual situation in their territories, endeavor to capture blank markets and strengthen weak areas by means of popularizing the technique. They are also required to assess the work of subordinates and coordinate assignments. As the leaders at the basic level of the system, the area managers are directly responsible for fulfilling required sales volume and work as direct administrators of sale teams. In this way, the principle of technique pioneering market is implemented down to the most basic level to provide the most direct technique service for area-sale marketing and sale.

Trading

Along with the development in technology and trade, MEBO Group has formed a comprehensive trade system, including an international trade office based on Global MEBO Group Inc. in Los Angeles of U.S.A and a domestic one on Beijing MEBO High-Tech Corporation Ltd. With technological predominance in the development of life science, MEBO Group is focused its trade transactions on the advanced life science technology and high-tech products.

The success of Professor Rongxiang Xu's medical team in treating Thailand burn patients in Bangkok gas explosion in 1990 contributed to the registration and marketing of MEBO Burn ointment and popularization of MEBT in Thailand. MEBT has been currently applied in several hospitals and clinics to treat burn and ulcer patients. In 1996, followed by the establishment of MEBO Thailand Corporation Ltd., the largest pharmaceutical company in Thailand has committed to market MEBO.

MEBO marketing in Middle East began with Professor Rongxiang Xu successfully treating a little princess of United Arab Emirates and Syrian military army burn patients. The cooperation with Unipharm of Syria and with Julphar of UAE was initiated successively in 1996. The success in above two countries directly led to MEBO products registration in 9 Middle East countries. The transaction amount according to the signed agreement with the two countries has exceeded 10 million US dollars per year. In 1996, MEBO was approved to be imported and marketed in South Korea, the third largest medicine market in Asia. Followed by Professor Rongxiang Xu's trips on academic to South Korea and doctors from South Korea visiting and being trained in China, an overall MEBO burn ointment entering into Korean medicine markets has been witnessed.

As the first step entering Europe and American markets, in 1996 MEBO was licensed to market in UK and some Western European Community countries as botanic skin care products and are available in several European chain stores. Meanwhile, aiming to gain FDA's approval as a botanic medicine, MEBO has been granted two U.S. patents and has had access to the FDA approval procedure after Professor Rongxiang Xu's triple visits to USA. Thus, the efforts to explore FDA approval so as to get overall entrance to markets worldwide have fully launched in Los Angeles headquarters of Group.

Beijing MEBO High-Tech Corporation Ltd. was registered in 1995 as the principal part of domestic trade and capital operation. It dedicates to evolving into a modern enterprise integrated with high-technology, products trading as well as capital operation. On the one hand, MEBO Corp. is independently exploring the market for MEBO skin care products like SCAReducer and Soften Beauty Cream, etc. backed by technological advantages of the Group. On the other hand, MEBO Corp. is seeking the promising projects in the areas of medicine, biological engineering and other technologies for cooperating, or investing to develop new products after purchasing, or simply trading. In addition, the Corp. is looking for the possibility of merging matched enterprises in the manner of capital operation for more rapid development.